Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
8.61
+0.28 (3.36%)
Sep 26, 2025, 4:08 PM HKT

Beijing Biostar Pharmaceuticals Company Description

Beijing Biostar Pharmaceuticals Co., Ltd., a synthetic biology-driven biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology products in the People’s Republic of China.

The company develops Utidelone injection, a microtubule inhibitor for the treatment of advanced and neoadjuvant breast cancer, advanced non-small cell lung cancer, gastric and esophageal cancer, brain metastasis, solid tumors, and glioblastoma.

It is also involved in the development of Utidelone capsule that is in Phase II/III clinical trials; Utidelone nanoformulation; and Utidelone antibody drug conjugate, as well as other active pharmaceutical ingredients, such as BG22, BG18, and BG44 in early development stages.

The company develops its pharmaceutical products through its technology platforms, including combinatorial biosynthesis, microbial fermentation production, and microbial drug formulation development platforms.

In addition, it provides medical consultation services. Beijing Biostar Pharmaceuticals Co., Ltd. was incorporated in 2002 and is headquartered in Beijing, China.

Beijing Biostar Pharmaceuticals Co., Ltd.
CountryChina
Founded2002
IndustryDrug Manufacturers - General
SectorHealthcare
Employees147
CEORongguo Qiu

Contact Details

Address:
Building 3, Tower B, Yicheng Fortune Center
Beijing, 100176
China
Phone86 10 6786 4938
Websitebiostar-pharm.com

Stock Details

Ticker Symbol2563
ExchangeHong Kong Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100006NB3
SIC Code2836

Key Executives

NamePosition
Dr. Rongguo QiuCo- Founder, Vice-Chairperson, Chief Executive Officer and GM
Dr. Li TangCo-Founder, Chairperson, Chief Scientific Officer and Chief Marketing Officer
Cheng ZhangDeputy GM, Vice President and Executive Director
Dr. Jin GuanDeputy GM and Executive Director
Fei PengFinancial Director
Xin ChenOperation Director
Kailin LiuInvestment Director and Joint Company Secretary
Wei HeHead of administration
Aoshuang HuangHuman Resource Director
Mingwu YangHead of equipment power